# Quality of Life Study for Sickle Cell Patients Treated With Jobelyn (Sorghum Bicolor Extract)

> **NCT01704794** · PHASE1,PHASE2 · UNKNOWN · sponsor: **Lagos State University** · enrollment: 96 (estimated)

## Conditions studied

- Other Sickle-cell Disorders With Crisis, Unspecified

## Interventions

- **DIETARY_SUPPLEMENT:** Folic Acid + Paludrine + Jobelyn (500mg)
- **DRUG:** Folic Acid + Paludrine + Jobelyn (250mg)
- **DIETARY_SUPPLEMENT:** Folic Acid + Paludrine + Jobelyn (2mg)

## Key facts

- **NCT ID:** NCT01704794
- **Lead sponsor:** Lagos State University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2014-04
- **Final completion:** 2014-09
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2013-04-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01704794

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01704794, "Quality of Life Study for Sickle Cell Patients Treated With Jobelyn (Sorghum Bicolor Extract)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01704794. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*